STOCK TITAN

Safe & Green Holdings Corp Announces Addition of Halo Precision Diagnostics™ Into Point-of-care Healthcare Model Being Built in Partnership With Peoples Health Care

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags
partnership
Rhea-AI Summary

Safe & Green Holdings Corp. (NASDAQ: SGBX) has announced its partnership with HALO Precision Diagnostics and The Peoples Health Care to enhance patient-centered healthcare. The initiative aims to provide deployable medical infrastructure, targeting a $52B healthcare market by 2030. The company plans to deliver four mobile medical modules to Teamsters Local 848 by year-end 2023, offering services such as wellness visits, lab medicine, and diagnostics. This collaboration strives to improve healthcare access and quality in underserved areas, with HALO's diagnostics being integral to the strategy. The focus is on sustainable healthcare and efficient delivery methods to meet growing demands.

Positive
  • Planned delivery of four mobile medical modules by end of 2023 to Teamsters Local 848.
  • Targeting a significant $52B healthcare market by 2030.
  • Partnership with HALO Precision Diagnostics aims to improve access and efficiency in healthcare delivery.
Negative
  • None.

HALO Precision Diagnostics (HALO) is an integrated healthcare diagnostics company offering rapid, precise, and actionable results that create life-changing and life-saving individualized plans for patients.

The Peoples Health Care is a California based non-profit organization committed to investing in the quality of care offered to the lives covered within California.

MIAMI--(BUSINESS WIRE)-- Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green Holdings'' or the “Company”), a leading developer, designer, and fabricator of modular structures, announced today that the Company is further solidifying its position as a leader in proactive, patient-centered healthcare deliverance. Safe & Green Holdings is building off of its proven business model of providing deployable and sustainable infrastructure in order to capitalize on the healthcare industry’s paradigm shift to point-of-care health models. The Company plans to bring higher quality and more equitable healthcare to underserved communities, while capturing its share of what is expected to be a nearly $52B market before the turn of 2030. Incorporating HALO Precision Diagnostics into this mission is expected to unlock care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models, making them an ideal partner for Safe & Green Holdings and The Peoples Health Care.

(Photo: Business Wire)

(Photo: Business Wire)

The Peoples Health Care is a California based non-profit organization committed to investing in the quality of care offered to the lives covered within California. As part of this mission, Safe & Green Holdings is beginning their alignment with Teamsters Local 848 by delivering four (4) full mobile medical modules to the union, redefining pathways and deployment, increasing access to care, and ensuring that the union members and their families have a personalized and defined path to improved outcomes.

By the conclusion of 2023, Safe & Green Holdings will have delivered one (1) Testing Module, one (1) CLIA Lab Facility Module and two (2) Primary Care Modules, all ADA compliant, and equipped to unlock quality care for the Teamsters Local 848 population. Services are expected to begin with general wellness visits, vaccines, laboratory medicine, select specialty visits, urgent care, imaging, diagnostics, and pharmacy services, making Halo an important partner in this mission.

“At Safe & Green Holdings, we are committed to shaping the future of medicine through sustainable and nimble healthcare solutions that empower the patient. To us, that means ensuring accessible, convenient, and agile care, for both patients and providers. The current centralized healthcare model is unable to easily adapt to the consumerization of healthcare services, and we intend to be the solution for lives here in the United States and abroad,” said Paul Galvin, Chairman and CEO of Safe & Green Holdings Corp. “We are incredibly proud to partner with HALO Precision Diagnostics and The Peoples Health Care, two progressive and focused organizations, so that we can, together, unlock improved health outcomes for the lives of Local 848,” continued Galvin.

“Collectively with Safe & Green Holdings, we have committed ourselves to empowering union members with accessible, affordable, and democratized precision diagnostic healthcare,” explained HALO CEO Michael Uhl. “This is a powerful way to expand our collective reach in order to bring personalized healthcare to patients, and we are thrilled to be part of such a novel ecosystem with the teams at Safe & Green Holdings,” continued Uhl.

The Company will continue to provide updates as the medical modules are delivered and new partners are engaged.

About Safe & Green Holdings Corp.
Safe & Green Holdings Corp., a leading modular solutions company, operates under core capabilities which include the development, design, and fabrication of modular structures, meeting the demand for safe and green solutions across various industries. The firm supports third party and in-house developers, architects, builders and owners in achieving faster execution, greener construction, and buildings of higher value. Safe and Green Development Corporation is a leading real estate development company. Formed in 2021, the company focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories and operated by SG Echo. For more information, visit www.safeandgreenholdings.com and follow us at @SGHcorp on Twitter.

About HALO Precision Diagnostics
HALO Precision Diagnostics is the leader in early disease detection using precision diagnostics. The company's outpatient Precision Diagnostic Centers are reshaping the healthcare ecosystem by integrating advanced imaging, digital pathology, molecular genomics, and predictive analytics under one roof, in a lower-cost, outpatient setting. HALO makes early-stage disease screening and diagnosis faster and more convenient for patients and physicians alike. With a HALO PathWay for breast, prostate, neuro, and cardiac disease, HALO is increasing early disease detection and saving lives. HALO currently serves 1 million patients, a number expected to triple by 2024. For more information, visit halodx.com.

Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the Company capitalizing on the healthcare industry’s paradigm shift to point-of-care health models, bringing higher quality and more equitable healthcare to underserved communities, capturing a share of what is expected to be a nearly $52B market before the turn of 2030, incorporating HALO Precision Diagnostics into the Company’s mission unlocking care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models, HALO being an ideal partner for Safe & Green Holdings and The Peoples Health Care, delivering four (4) full mobile medical modules to the Teamsters Local 848 by the conclusion of 2023, redefining pathways and deployment, increasing access to care, and ensuring that the union members and their families have a personalized and defined path to improved outcomes, services beginning with general wellness visits, vaccines, laboratory medicine, select specialty visits, urgent care, imaging, diagnostics, and pharmacy services, shaping the future of medicine through sustainable and nimble healthcare solutions that empower the patient, being the solution for lives here in the United States and abroad and providing updates as medical modules are delivered and new partners are engaged. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company’s ability to capitalize on the healthcare industry’s shift to point-of-care health models, the Company’s ability to bring higher quality and more equitable healthcare to underserved communities and capture a share of what is expected to be a nearly $52B market before the turn of 2030, the Company’s ability to unlock care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models by incorporating HALO Precision Diagnostics into the Company’s mission, the Company’s ability to deliver four (4) full mobile medical modules to the Teamsters Local 848 by the conclusion of 2023, the Company’s ability to provide medical and pharmacy services as planned, the Company’s ability to engage new partners, the Company’s ability to spin out Safe and Green Development Corporation, the Company’s ability to expand within various verticals as planned, the Company’s ability to position itself for future profitability, the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Investor Relations:

Crescendo Communications, LLC

212-671-1020

SGBX@crescendo-ir.com

Source: Safe & Green Holdings Corp.

FAQ

What is the significance of Safe & Green Holdings' partnership with HALO Precision Diagnostics?

The partnership aims to enhance patient-centered healthcare and improve access to medical services, targeting a $52B market.

What services will be provided through the mobile medical modules delivered by SGBX?

The mobile medical modules will offer wellness visits, vaccines, laboratory medicine, urgent care, diagnostics, and pharmacy services.

When does SGBX plan to deliver the mobile medical modules to Teamsters Local 848?

Safe & Green Holdings plans to deliver the modules by the end of 2023.

What is the business strategy of Safe & Green Holdings regarding healthcare?

The company focuses on deploying sustainable healthcare infrastructure in underserved communities.

What market opportunities does SGBX see by 2030?

Safe & Green Holdings aims to capture a share of the expected $52B healthcare market.

Safe & Green Holdings Corp.

NASDAQ:SGBX

SGBX Rankings

SGBX Latest News

SGBX Stock Data

1.17M
1.71M
24.13%
5.95%
18.64%
Metal Fabrication
Wholesale-lumber & Other Construction Materials
Link
United States of America
BROOKLYN